Skip to main content
LUYAN PHARMA CO.,LTD logo

LUYAN PHARMA CO.,LTD — Investor Relations & Filings

Ticker · 002788 ISIN · CNE1000025W1 Shenzhen Stock Exchange Wholesale and retail trade
Filings indexed 1,022 across all filing types
Latest filing 2016-01-20 Legal Proceedings Report
Country CN China
Listing Shenzhen Stock Exchange 002788

About LUYAN PHARMA CO.,LTD

https://www.luyan.com.cn

Luyan Pharma Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive logistics network, providing supply chain management services to healthcare institutions, including hospitals and community clinics. Its product portfolio encompasses a wide range of Western pharmaceuticals, traditional Chinese medicines, and medical equipment. In addition to wholesale distribution, the company maintains a significant presence in the retail pharmacy sector through a chain of drugstores. Luyan Pharma focuses on optimizing healthcare delivery through integrated distribution systems and value-added services, such as third-party logistics and pharmaceutical cold chain management. The organization leverages its regional market leadership to expand its service footprint and enhance the efficiency of the medical supply chain.

Recent filings

Filing Released Lang Actions
北京市金杜律师事务所关于公司首次公开发行股票并上市的补充法律意见书(九)
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter issued by a law firm (北京市金杜律师事务所) regarding the company's initial public offering (IPO) and listing process. It references multiple prior legal opinion letters and reports related to the IPO, discusses compliance with relevant laws and regulations, and confirms the legality of the company's fundraising investment projects. The document is a supplementary legal opinion letter, which is a type of legal proceeding or regulatory compliance document related to the IPO process. It does not contain financial statements, earnings data, or management discussion, nor is it a report publication announcement. It is not a direct financial report but a legal proceeding update. Therefore, the most appropriate classification is Legal Proceedings Report (LTR). The document length is 3376 characters, which is relatively short but contains substantive legal content rather than a mere announcement or certification, so it is not RNS or RPA.
2016-01-20 Chinese
中国证监会关于核准公司首次公开发行股票的批复
Regulatory Filings
2016-01-20 Chinese
第二届董事会第十九次会议决议
Regulatory Filings
2016-01-20 Chinese
第三届董事会第四次会议决议
Regulatory Filings
2016-01-20 Chinese
第三届董事会第十一次会议决议
Regulatory Filings
2016-01-20 Chinese
审计报告
Regulatory Filings
2016-01-20 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.